CANNABIS BUSINESS PLAN

I. Executive Summary

Company Description

GreenGrid Cultivation—named for its grid-based, data-driven growing system—launches in 2026 as a technology-focused cannabis cultivation enterprise serving the U.S. B2B market. We produce premium, lab-tested cannabis biomass and flower for manufacturers and multi-state operators. Our product lineup is built for consistency and compliance: standardized cannabinoid profiles, batch-level lab certificates, and harvest-scheduled volumes that reduce supply volatility for downstream processors. One-line summary: we sell predictable, high-quality cannabis at scale to B2B customers.

Operations center on precision cultivation, tight harvest planning, and rigorous quality control in a state-of-the-art facility using sensors, automated environment controls, and analytics. These activities ensure repeatable yields, short lead times, and traceable lots that set us apart from traditional growers. Target customers are manufacturers and multi-state operators who need reliable inputs. Short-term goal: commence commercial shipments in 2026 and achieve steady monthly supply by year-end. Long-term goal: secure national supply agreements and become a critical infrastructure partner for large-scale cannabis processors and M.S.O.s.

Problem

U.S. cannabis manufacturers and dispensaries suffer from inconsistent supply and variable product quality, causing production delays, retail stockouts, recipe failures for infused products, and damaged buyer trust. Fluctuating cannabinoid profiles and purity levels make batch forecasting and cost control impossible for downstream partners.

Existing wholesale channels and traditional growers do not provide the transparency, yield reliability, or lab-tested consistency industrial buyers require, leaving manufacturers and multi-state operators exposed to margin compression and operational risk—so the market needs a predictable, quality-first B2B cultivation partner.

Solution

We solve the market problem of inconsistent supply and variable product quality by operating a state-of-the-art controlled-environment facility that delivers lab-tested cannabis to B2B partners year‑round. Our data-driven environmental controls and nutrient delivery produce a diverse product mix—high-potency flower, mid-grade flower, and biomass for extraction—providing a steady, reliable supply that removes inventory gaps and standardizes cannabinoid profiles for manufacturers and retailers.

One line: We provide year‑round, lab‑tested, and predictable wholesale cannabis supply for manufacturers and dispensaries.

Mission Statement

We stabilize the U.S. cannabis supply chain by delivering the most reliable, consistent, and high-quality B2B cannabis products through technological innovation and operational excellence. We commit to transparency, regulatory compliance, and measurable quality so every harvest meets precision and purity standards. We drive long-term growth and sustainability by setting the industrial standard for data-driven cultivation and supporting partner success.

Key Success Factors

Our success hinges on predictable supply, operational efficiency, contract-backed demand, strict compliance, and scalable margins.

• Supply chain predictability via optimized harvest frequency and yield management.
• Operational efficiency that cut yield loss from 12% to 3.5% over ten years.
• Revenue stability secured by long-term B2B supply contracts and high facility utilization.
• Regulatory integrity through 100% compliance and rigorous third-party testing.
• Scalable economics driving EBITDA from $5.8M to over $65M by 2035.

Financial Summary

Financial summary for the Executive Summary: the project reaches breakeven in January 2026 with rapid EBITDA growth as cultivated area expands.

Financial requirements: initial capital expenditures $2,028,000; minimum cash required $866,000 (minimum cash month Jan-26). Anticipated returns include an IRR of 6.15% and reported ROE of 333.71%; payback and breakeven occur in Month 1 (Jan-26).

Overall outlook: breakeven immediately and EBITDA rising to $65.636M by year 10.

Funding Requirements

The project requires a one-time capital injection to cover 2026 launch capital expenditures, a minimum January 2026 cash reserve, and the first year of fixed facility expenses, totaling USD 3,116,000.